 |
Европейская академия
|
| В начало | Энциклопедия ЕАЕН | |
Энциклопедия Европейской академии естественных наук |
||
Gong Honghai
Gong Honghai, a Doctor of Medicine from the China Academy of Chinese Medical Sciences. From a young age, influenced by a family steeped in the tradition of Chinese medicine, I developed a deep love for the field and aspired to become a skilled practitioner. Selected by my family, I was designated as the ninth-generation heir of the Gong family's legacy in Chinese medicine, notable for our secret method of pulse diagnosis using both hands, and for treating cardiovascular and cerebrovascular diseases with traditional Chinese medicine.
Over more than 30 years of research and practice, I have mastered clinical classics and strategic medication, integrating Chinese and Western medical knowledge with a unique and innovative approach that respects tradition without being constrained by it. I have created a series of methods for treating cardiovascular and cerebrovascular diseases, gaining recognition in the medical community and being hailed by patients as "the guardian of heart health." In my spare time, I often educate the public on medical knowledge and have been invited as a health expert on programs like Beijing TV's "Health Forum."
In 2018, the "Gong's Heart-Preserving Decoction" was submitted as the "Shenqi Yixin Granules" research project to the Beijing Municipal Food and Drug Administration. The product was successful in animal testing and positive drug control group trials. Although its analgesic effect is not as immediate as nitroglycerin, it has shown superior long-term benefits. In terms of reducing blood lipids and thrombolysis, it outperformed the positive control group in comparative studies. Clinical validation has shown that "Shenqi Yixin Granules" can improve myocardial blood supply insufficiency and correct symptoms of heart failure, coronary heart disease, and angina pectoris. After 2-3 treatment courses, patients with coronary artery constriction of 70% have seen a reduction to 20%, with most cases of coronary heart disease constriction being completely resolved.
| Энциклопедия ЕАЕН |